Summit Creek Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FAM
Summit Creek Advisors's NEO Position: Q2 2021 in Review
Summit Creek Advisors sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 172,081 shares — an estimated $8.3M sold.
Summit Creek Advisors first reported a position in NEO in Q3 2015 and held it in 23 quarters. The position peaked at $15.7M in Q3 2018. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.
- Summit Creek Advisors reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
- Summit Creek Advisors sold 172,081 NeoGenomics shares in Q2 2021, an estimated $8.3M.
- Summit Creek Advisors first reported a position in NeoGenomics in Q3 2015 and held it in 23 quarters.
- Summit Creek Advisors's NeoGenomics position peaked at $15.7M in Q3 2018.
- 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.
Based on Summit Creek Advisors's 13F filing for Q2 2021, filed 4 Aug 2021.